News
Novavax Inc. shares rose after US regulators asked for more data on its Covid vaccine, signaling the shot may be on a path to ...
When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...
Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...
The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including ...
ATHENS, Ga. & SAN JOSE, Calif., March 27, 2025--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...
are a result of scientific review to ensure safety and efficacy," an HHS official familiar with the situation told Reuters. "If they don't approve Novavax, they put every COVID vaccine at risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results